Cargando…
Progesterone Receptor Membrane Component 1 (PGRMC1) Modulates Tumour Progression, the Immune Microenvironment and the Response to Therapy in Glioblastoma
Progesterone Receptor Membrane Component 1 (PGRMC1) is a tumour-promoting factor in several types of cancer but its role in brain tumours is poorly characterized thus far. Our study aimed to determine the effect of PGRMC1 on glioblastoma (GBM) pathophysiology using two independent cohorts of IDH wil...
Autores principales: | Dumitru, Claudia Alexandra, Schröder, Hannah, Schäfer, Frederik Till Alexander, Aust, Jan Friedrich, Kreße, Nina, Siebert, Carl Ludwig Raven, Stein, Klaus-Peter, Haghikia, Aiden, Wilkens, Ludwig, Mawrin, Christian, Sandalcioglu, Ibrahim Erol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604944/ https://www.ncbi.nlm.nih.gov/pubmed/37887342 http://dx.doi.org/10.3390/cells12202498 |
Ejemplares similares
-
PLOD2 Is a Prognostic Marker in Glioblastoma That Modulates the Immune Microenvironment and Tumor Progression
por: Kreße, Nina, et al.
Publicado: (2022) -
Brain biopsy in patients with CLIPPERS syndrome: why and when
por: Galazky, Imke, et al.
Publicado: (2022) -
Progesterone Receptor Membrane Component (PGRMC)1 and PGRMC2 and Their Roles in Ovarian and Endometrial Cancer
por: Peluso, John J., et al.
Publicado: (2021) -
Extravascular optical coherence tomography of cerebral vessel walls in vivo
por: Hartmann, Karl, et al.
Publicado: (2023) -
Is the central nervous system enclosed by a mesothel?
por: Hartmann, Karl, et al.
Publicado: (2023)